D294-3099 Screening compound: N-{5-[1-(4-ethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl}-4-(2-methylpropanamido)benzamide

D294-3099 Screening compound: N-{5-[1-(4-ethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl}-4-(2-methylpropanamido)benzamide
D294-3099 Screening compound: N-{5-[1-(4-ethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl}-4-(2-methylpropanamido)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D294-3099
N-{5-[1-(4-ethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl}-4-(2-methylpropanamido)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D294-3099

Molecular Formula

C25H27N5O3S (C25 H27 N5 O3 S)

Compound Name

N-{5-[1-(4-ethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl}-4-(2-methylpropanamido)benzamide

IUPAC name

N-{5-[1-(4-ethylphenyl)-5-oxopyrrolidin-3-yl]-134-thiadiazol-2-yl}-4-(2-methylpropanamido)benzamide

SMILES

CCc(cc1)ccc1N(CC(C1)c2nnc(NC(c(cc3)ccc3NC(C(C)C)=O)=O)s2)C1=O

InChI

InChI=1S/C25H27N5O3S/c1-4-16-5-11-20(12-6-16)30-14-18(13-21(30)31)24-28-29-25(34-24)27-23(33)17-7-9-19(10-8-17)26-22(32)15(2)3/h5-12,15,18H,4,13-14H2,1-3H3,(H,26,32)(H,27,29,33)/t18-/m0/s1

InChI Key

BTRUSPVFECVZGC-SFHVURJKSA-N

MDL Number (MFCD)

MFCD09271559

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.273

Distribution Coefficient, logD

3.140

Water Solubility, LogSw

-4.05

Polar Surface Area

86.716

Acid Dissociation Constant (pKa)

6.30

Base Dissociation Constant (pKb)

-0.68

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.00

D294-3099 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

C-Met Library (15277 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with D294-3099 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D294-3099?
Check Price and Availability of D294-3099, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D294-3099 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D294-3099
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D294-3099
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D294-3099 available by request